SP-MHCI-0607-2

Human HLA class I antigen 3-11, VMAPRTLVL

US$169.00

In stock

Description

About Human HLA class I antigen 3-11, VMAPRTLVL

The Human HLA class I antigen Peptide (IEDB: 69922) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The HLA class I antigen Peptide, H-VMAPRTLVL-OH (Uniprot: Q53Z42  aa: 3-11) from JPT is produced under strict quality control and quality management.

Human HLA class I antigen 3-11, VMAPRTLVL - Specifications

  • Peptide sequence: H-VMAPRTLVL-OH
  • Amount: 1 mg
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Multiple sclerosis, Autoimmune disease, Infection
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Peptide Synthesis Services!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Human HLA class I antigen 3-11, VMAPRTLVL

References:
Read References with JPT’s Antigen Peptides
Human HLA class I antigen 3-11, VMAPRTLVL has been described in:
HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes., Hum Immunol, 2004 (PMID: 15172443)
HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes., Proc Natl Acad Sci U S A, 2003 (PMID: 12960383)
HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy., J Immunother Cancer, 2021 (PMID: 33858848)

Documentation

Documentation for Human HLA class I antigen 3-11, VMAPRTLVL

Properties

Properties of Human HLA class I antigen 3-11, VMAPRTLVL

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Autoimmune disease, Infection, Multiple sclerosis
Layout: Freeze-dried in glass vial
Organism: Human
Protein Name: HLA class I antigen
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Human HLA class I antigen 3-11, VMAPRTLVL

Information Values
Sequence: H-VMAPRTLVL-OH
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote